Your browser is no longer supported. Please, upgrade your browser.
Settings
OPXA Opexa Therapeutics, Inc. daily Stock Chart
OPXA [NASD]
Opexa Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.53 Insider Own0.80% Shs Outstand53.22M Perf Week-8.25%
Market Cap23.68M Forward P/E- EPS next Y-0.30 Insider Trans0.00% Shs Float50.38M Perf Month-11.00%
Income-14.70M PEG- EPS next Q-0.08 Inst Own4.60% Short Float3.82% Perf Quarter-19.03%
Sales1.30M P/S18.22 EPS this Y56.80% Inst Trans49.08% Short Ratio1.21 Perf Half Y-42.96%
Book/sh0.13 P/B3.42 EPS next Y16.70% ROA-103.10% Target Price5.00 Perf Year-73.19%
Cash/sh0.18 P/C2.47 EPS next 5Y- ROE-168.40% 52W Range0.33 - 1.71 Perf YTD-38.19%
Dividend- P/FCF- EPS past 5Y-3.30% ROI-202.70% 52W High-73.98% Beta2.08
Dividend %- Quick Ratio1.90 Sales past 5Y- Gross Margin- 52W Low34.85% ATR0.06
Employees39 Current Ratio1.90 Sales Q/Q33.30% Oper. Margin- RSI (14)43.61 Volatility10.12% 12.35%
OptionableNo Debt/Eq0.00 EPS Q/Q7.70% Profit Margin- Rel Volume0.58 Prev Close0.43
ShortableYes LT Debt/Eq0.00 EarningsMay 12 AMC Payout- Avg Volume1.59M Price0.44
Recom2.00 SMA20-15.00% SMA50-2.89% SMA200-37.65% Volume921,658 Change3.61%
May-27-15Initiated Maxim Group Buy $5
May-30-14Initiated Aegis Capital Buy $4
Mar-30-10Initiated Rodman & Renshaw Mkt Outperform $6
Feb-20-07Initiated MDB Capital Group Buy $8
Jun-11-15 08:00AM  Opexa Therapeutics CEO to Present at BIO 2015 International Convention Business Wire
Jun-09-15 08:00AM  Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development Business Wire
Jun-04-15 04:16PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
Jun-02-15 04:44PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St +14.80%
May-27-15 05:41AM  Coverage initiated on Opexa Therapeutics by Maxim Group +34.81%
May-22-15 01:04PM  OPEXA THERAPEUTICS, INC. Financials
May-21-15 08:00AM  Opexa Therapeutics to Present at the 2015 Marcum Microcap Conference Business Wire
May-14-15 08:11PM  10-Q for Opexa Therapeutics, Inc. at Company Spotlight -7.10%
May-13-15 08:00AM  Opexa Therapeutics CEO Invited to Participate in Multiple May Conferences Business Wire +10.18%
May-12-15 04:06PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
04:01PM  Opexa Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update Business Wire
07:07AM  Q1 2015 Opexa Therapeutics Inc Earnings Release - After Market Close
May-11-15 08:00AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2015 Financial Results Business Wire
Apr-20-15 08:15AM  Opexa Therapeutics Invited to Present Biomarker Data from NMO Patients at The American Academy of Neurology (AAN) 2015 Annual Meeting at noodls
08:00AM  Opexa Therapeutics Invited to Present Biomarker Data from NMO Patients at The American Academy of Neurology (AAN) 2015 Annual Meeting Business Wire
Apr-09-15 07:06AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:04AM  Opexa Therapeutics, Inc. Announces Completion of Rights Offering at noodls
07:00AM  Opexa Therapeutics, Inc. Announces Completion of Rights Offering Business Wire
Apr-06-15 08:03AM  Opexa Therapeutics Reminds Shareholders That Rights Offering Expires on April 8, 2015 at 5:00 PM ET at noodls
08:00AM  Opexa Therapeutics Reminds Shareholders That Rights Offering Expires on April 8, 2015 at 5:00 PM ET Business Wire
Apr-01-15 06:14AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events -7.08%
Mar-18-15 04:31AM  Opexa Therapeutics Reminds Shareholders That Rights Offering Ownership Date and Time is Tuesday, March 10, 2015 at 4:00 PM ET at noodls
Mar-10-15 05:16PM  Merck KGaA to Pay $3M to Opexa for Tcelna Study - Analyst Blog +7.94%
09:24AM  Opexa Therapeutics Reports Year End 2014 Financial Results and Provides Corporate Update at noodls
09:00AM  Opexa Therapeutics Reminds Shareholders That Rights Offering Ownership Date and Time is Tuesday, March 10, 2015 at 4:00 PM ET Business Wire
Mar-09-15 07:13AM  Opexa Therapeutics, Inc. Announces Record Date and Subscription Price for Rights Offering at noodls -6.23%
07:13AM  Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna┬« for Multiple Sclerosis at noodls
07:02AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh
07:00AM  Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna┬« for Multiple Sclerosis Business Wire
Feb-25-15 07:08PM  10-K for Opexa Therapeutics, Inc. at Company Spotlight +5.63%
05:22PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:10PM  Opexa Therapeutics, Inc. Announces Record Date and Subscription Price for Rights Offering Business Wire
Feb-23-15 06:11AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online -5.48%
06:05AM  Opexa Therapeutics Reports Year End 2014 Financial Results and Provides Corporate Update Business Wire
06:04AM  OPEXA THERAPEUTICS, INC. Files SEC form 10-K, Annual Report EDGAR Online
Jan-28-15 06:13AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -6.41%
06:05AM  Opexa Therapeutics, Inc. Files Registration Statement for Rights Offering Business Wire
Dec-16-14 03:52PM  Dave Gentry Features Top 5 Healthcare Stocks for 2015 on This Week's RedChip Money Report on Fox Business and Bloomberg GlobeNewswire
Dec-11-14 10:35AM  Small Cap Profiles: OPXA, NEWC, TRNS, MLER Accesswire
Dec-09-14 05:16PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St EDGAR Online
Nov-18-14 09:00AM  Opexa Therapeutics Selected as One of the Top 10 Advanced Therapy Projects to Watch Business Wire
Nov-11-14 09:00AM  Opexa Therapeutics CEO Invited to Join Personalized Medicine Panel at New York CEO Conference Business Wire
Nov-08-14 07:07PM  10-Q for Opexa Therapeutics, Inc. Company Spotlight
Nov-06-14 04:03PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online +5.73%
04:01PM  Opexa Therapeutics Reports Third Quarter 2014 Financial Results and Provides Corporate Update Business Wire
Nov-05-14 09:00AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2014 Financial Results Business Wire -7.44%
Oct-22-14 09:00AM  Opexa Therapeutics Supports National Multiple Sclerosis Society and Walk MS Business Wire +6.12%
Oct-20-14 09:00AM  Opexa Therapeutics to Present at Cleveland Clinics 12th Annual Medical Innovation Summit Business Wire
Oct-09-14 07:00AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Oct-06-14 11:15AM  RedChip Announces Presentation Schedule for Its October 15-16 Online Investor Conference GlobeNewswire
Oct-02-14 02:09PM  Opexa Therapeutics Announces Analyst and Investor Event Business Wire
Sep-29-14 09:01AM  Opexa Strengthens Patent Portfolio with Expansion Into B-cell Diseases and Announces Allowance of 98th T-cell Patent Business Wire
Sep-16-14 08:36AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -12.60%
08:30AM  Opexa Therapeutics, Inc. Announces Termination of Public Offering of Common Stock Business Wire
Sep-15-14 04:25PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -5.22%
04:21PM  Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock Business Wire
Sep-11-14 04:45PM  Momenta Gains on Purchase of Autoimmune Antibodies Zacks
Sep-08-14 07:30AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07:29AM  Opexa Therapeutics to Target Rare Disease Neuromyelitis Optica (NMO) as next Development Program Business Wire
Sep-02-14 09:00AM  Opexa Therapeutics to Present at September Conferences Business Wire
Aug-14-14 04:23PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure EDGAR Online
04:05PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:01PM  Opexa Therapeutics Reports Second Quarter 2014 Financial Results and Provides Corporate Update Business Wire
Aug-11-14 09:00AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Second Quarter 2014 Financial Results Business Wire
Jul-17-14 10:58AM  RedChip Issues Research Profile on Opexa Therapeutics GlobeNewswire
Jul-08-14 11:30AM  RedChip's July 16-17 Global Online CEO Conference Presentation Schedule Now Available GlobeNewswire
Jun-30-14 08:00AM  Opexa Therapeutics Joins Russell Microcap Index Business Wire
Jun-26-14 09:25AM  RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg GlobeNewswire
Jun-25-14 04:06PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-03-14 09:24AM  Opexa Is Personalizing The Treatment Of Autoimmune Disease at Seeking Alpha
May-29-14 08:37AM  RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg GlobeNewswire +7.64%
May-14-14 04:13PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure EDGAR Online
04:06PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04:01PM  Opexa Therapeutics Reports First Quarter 2014 Financial Results and Provides Corporate Update Business Wire
May-13-14 08:04AM  Opexa Therapeutics reaches enrollment target in Phase IIb trial at theflyonthewall.com
08:03AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibit EDGAR Online
08:00AM  Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis Business Wire
May-12-14 08:00AM  Opexa Therapeutics Announces News Release and Conference Call to Discuss First Quarter 2014 Financial Results Business Wire
Apr-30-14 09:00AM  Opexa Therapeutics: An Optimal Buyout Candidate Pending Successful Topline Results From Abili-T at Seeking Alpha +8.11%
Apr-22-14 08:00AM  Opexa Therapeutics to Attend the American Academy of Neurology Annual Meeting Business Wire
Apr-21-14 10:23AM  RedChip Global Online CEO Conference, April 23-24, Featuring Presentations From 30+ Small-Cap Companies GlobeNewswire +6.71%
Apr-10-14 10:18AM  RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg GlobeNewswire
Mar-24-14 06:02AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Mar-21-14 08:00AM  Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa PR Newswire
Mar-20-14 08:01AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online
08:00AM  Opexa Therapeutics Appoints Prof. Hans-Peter Hartung and Timothy Barabe to the Board of Directors Business Wire
Mar-10-14 12:09PM  Opexa Therapeutics mentioned positively by Seeking Alpha contributor at theflyonthewall.com
12:09PM  Opexa Therapeutics moves up on a positive Seeking Alpha blog at theflyonthewall.com
12:04PM  Opexa Therapeutics: A Long-Term Perspective For Price Appreciation at Seeking Alpha
Mar-05-14 04:48PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online
Feb-28-14 06:04AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Feb-27-14 06:42PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
06:42PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-K, Annual Report EDGAR Online
04:20PM  Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update Business Wire
Feb-26-14 08:00AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results Business Wire
Feb-21-14 12:19PM  Will Opexa Become A Multi-Bagger? at Seeking Alpha
Feb-11-14 02:16PM  Opexa Therapeutics CEO to Present at the 2014 Leerink Global Healthcare Conference Business Wire
Jan-29-14 09:00AM  Opexa Therapeutics to Present at the 16th Annual BIO CEO & Investor Conference Business Wire
Jan-23-14 09:00AM  Opexa Therapeutics Chief Scientific Officer Invited as Guest Speaker at the Phacilitate Cell & Gene Therapy Forum Business Wire
Jan-07-14 07:30AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. The company's product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. It is also developing OPX-212 as an autologous T-cell immunotherapy for the treatment of NMO. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics was founded in 2003 and is based in The Woodlands, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARABE TIMOTHY CDirectorSep 17Buy1.1510,00011,50016,000Sep 18 08:00 AM
Warma Neil KPresident & CEOSep 16Buy1.1110,00011,100107,634Sep 17 08:00 AM